| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-17 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.66 | 5e-06 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |